UCSF’s innovative, collaborative approach to patient care, research and education spans disciplines across the life sciences, making it a world leader in scientific discovery and its translation to improving health.
An extended course of Paxlovid appears to help some patients with long COVID, according to a study by UCSF researchers that suggests this treatment option holds promise for some of those struggling with lasting symptoms.